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Abstract
Animal African Trypanosomosis (AAT) presents a severe problem for agricultural development in sub-Saharan Africa. It is
caused by several trypanosome species and current means of diagnosis are expensive and impractical for field use. Our aim
was to discover antigens for the detection of antibodies to Trypanosoma congolense, one of the main causative agents of
AAT. We took a proteomic approach to identify potential immunodiagnostic parasite protein antigens. One hundred and
thirteen proteins were identified which were selectively recognized by infected cattle sera. These were assessed for
likelihood of recombinant protein expression in E. coli and fifteen were successfully expressed and assessed for their
immunodiagnostic potential by ELISA using pooled pre- and post-infection cattle sera. Three proteins, members of the
invariant surface glycoprotein (ISG) family, performed favorably and were then assessed using individual cattle sera. One
antigen, Tc38630, evaluated blind with 77 randomized cattle sera in an ELISA assay gave sensitivity and specificity
performances of 87.2% and 97.4%, respectively. Cattle immunoreactivity to this antigen diminished significantly following
drug-cure, a feature helpful for monitoring the efficacy of drug treatment.
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Introduction
Animal African Trypanosomosis (AAT) presents a severe
problem for agricultural development in sub-Saharan Africa.
The economic loss in cattle production is estimated to be between
US$ 1 billion per annum [1–3], increasing to US$ 5 billion when
secondary costs are taken into consideration [1,3,4]. It is estimated
that around 60 million cattle are at risk in endemic regions [1,4].
In addition, AAT affects many other domestic livestock such as
pigs, camels, goats, sheep and horses. There are no vaccines and
treatment is usually via intramuscular administration using
trypanocides, either diminazene (therapeutically) or isometami-
dium (prophylactically). Current diagnostics methods are laborious
(microscopy), expensive (PCR) and generally impractical for use in
the field, at the point of treatment.
AAT is caused by several species of protozoan parasites of the
genus trypanosoma, including T. congolense, T. brucei, T. vivax and T.
evansi. [1]. T. congolense is the most pathogenic and main causative
agent of cattle AAT and is transmitted in Africa by tsetse flies of
the genus Glossina [1,5]. Symptoms of T. congolense AAT include
anaemia, weakness, weight loss and, in most untreated cases, death
[5,6]. These symptoms are often used to clinically diagnose AAT,
although they are congruent with many other anaemia causing
diseases prevalent in the endemic regions including babesiosis,
anaplasmosis, hemonchosis, and theileriosis. Wrong diagnosis is
costly and counter productive to efficient treatment.
Currently, specific diagnostics rely on microscopic detection of
the parasites, the laboratory detection of specific antibodies or the
detection of parasite DNA by PCR [5,6]. A card agglutination test
(CATT), such as that used to detect human African trypanoso-
mosis in the field, is available for T. evansi infections [5] but is not
applicable to T. congolense and T. vivax infections. Diagnosis in the
field for these pathogens currently relies on whole cell lysate tests
that suffer from antigen instability, reproducibility and specificity
problems [5].
With this in mind, we set out to discover new diagnostic
antigens for T. congolense that might be compatible with ELISA
assays and subsequent development into lateral flow devices.
In order to identify antigens for recombinant production and
test development, we utilised a proteomic approach similar to that
recently used to identify invariant surface glycoprotein (ISG) 65 as
a potential diagnostic antigen for human African trypanosomosis
[7]. Briefly, this method involves loading identical amounts of
parasite whole-cell detergent lysates onto identical amounts of
immobilized IgG isolated from the same animals before and after
experimental infection and then comparing, by label-free quan-
titative proteomics, the proteins subsequently eluted from the
immobilized IgGs and selecting those .100-fold more highly
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represented in the eluate from the immobilized infection IgG. This
is a systematic approach to antigen identification, as was the
identification of T. vivax GM6 from a cDNA expression library
screen with infected bovine sera [8,9]. Both are alternatives to
candidate-based approaches, whereby potential diagnostic anti-
gens are selected based on literature precedent. A successful
example of the latter for AAT is the selection of HSP70/BiP [10]
because, despite substantial conservation of sequence between
species, HSP70/BiP is known to be highly immunogenic.
Here, using the systematic proteomics approach, we report the
identification, production and evaluation of several new potential
diagnostic antigens. The two best performing antigens were both
ISG family members, one of which (Tc38630) has been recently
reported as a potential diagnostic antigen for T. congolense infections
using mouse sera [11]. In this study, we extensively characterise a
recombinant Tc38630 construct against diagnostically relevant
cattle sera and demonstrated its potential for the diagnosis of T.
congolense infections in bovines. We also demonstrate its ability to
distinguish, to some degree, between successful and failed drug
treatments.
Materials and Methods
Ethics statement
Rodents were used to propagate sufficient T. congolense parasites
to make the detergent lysates for immunoaffinity chromatography
and proteomics. The animal procedures were carried out
according the United Kingdom Animals (Scientific Procedures)
Act 1986 and according to specific protocols approved by The
University of Dundee Ethics Committee and as defined and
approved in the UK Home Office Project License PPL 60/3836
held by MAJF.
All cattle studies were reviewed by the ClinVet Animal Ethics
Committee (CAEC), who authorised the clinical research organi-
zation to conduct the studies (approval numbers CV12/884;
CV12/928 and CV12/885). The study protocols were designed to
allow the use of the study animals in compliance with the ClinVet
Policy on the ethical use of animals and the South African
National Standard ‘‘SANS 10386:2008 The care and use of
animals for scientific purposes’’. Permission to do research was
granted by the South African Department of Agriculture, Forestry
and Fisheries (DAFF) under Section 20 of the South African
Animal Diseases Act, 1984 (ACT NO. 35 of 1984).
Cattle sera from T. congolense infected and uninfected
animals
Cattle sera were obtained from experimental infections being
conducted as part of exploratory clinical efficacy studies, using
preliminary formulations of novel trypanocides, at ClinVet
International (Pty) Ltd and provided by GALVmed. All animals
were obtained from tsetse free areas and shown to below the limits
of trypanosomosis detection by polymerase chain reaction–
restriction fragment length polymorphism (PCR-RFLP) assay
[12], performed by the Molecular Diagnostic Services laboratory,
Department of Veterinary Tropical Diseases, Pretoria. Animals
were maintained in fly-proof facilities in a tsetse free area (ClinVet
International (Pty) Ltd, Bloemfontein, South Africa). Serum
samples for IgG purification were collected at either 7 days pre-
infection or 28 days post infection with T. congolense strains 02J and
31J from Centro de Biotecnologia, Faculdade de Veterina´ria,
Universidade Eduardo Mondlane, Maputo, Mozambique and
strains KONT2/133 and KONT2/151, isolated in 2004 from
naturally infected cattle in Kontcha, Cameroon and obtained from
the Institute of Tropical Medicine, Antwerp, Belgium. Each
animal was only infected with one strain.
Test sera were obtained from a total of forty calves from Clinvet
studies that were collected at weekly intervals until 98 days post-
infection (dpi). These animals were subjected to drug treatments
on dpi 10 or 35. Sera from 21, 0, 7, 14, 28, 35, 42, 49, 63, 77, 91
and 98 dpi were evaluated by ELISA. A panel of 77 randomised
and blinded (at source) T. congolense sera were also evaluated
against the best candidate antigen from this study. Parasitaemia
levels were monitored by microscopy and packed cell volume
(PCV) by standard methods [13].
IgG purification from serum
Aliquots (50 ml) of sera each from 13 post-infected (day +28) and
the same 13 pre-infected (day 27) calves were pooled separately.
Each pool was applied to a 1 ml protein G column (GE
Healthcare) equilibrated in phosphate buffered saline (PBS). The
columns were washed with 10 ml of PBS and the bound IgG
antibodies were eluted with 50 mM sodium citrate pH 2.8, and
collected in 1 ml fractions into tubes containing 200 ml of 1 M
Tris-HCl, buffer pH 8.5. Peak fractions containing IgG were
combined and dialysed for 16 h against coupling buffer (0.1 M
NaHCO3, 0.5 M NaCl, pH 8.3). The purified IgGs were then
coupled at 4 mgmL21 of packed gel to CNBr-activated Sepharose
4B beads following the procedures detailed in [7].
Preparation T. congolense lysate
Three BalbC mice were injected with one stabilate of T.
congolense strain IL 3000. After five days, mouse blood was
harvested with citrate anticoagulant, adjusted to 56104 parasites
per ml with PBS and aliquots of 0.2 ml (16104 mL21 parasites)
were injected into the peritoneal cavity of 44 NMR1 mice. The
mouse blood was harvested after 7 days with citrate anticoagulant
and centrifuged at 10006 g for 10 min at 4uC. Plasma was
removed and the buffy layer was resuspended in separation buffer
plus glucose (SB+glucose; 57 mM Na2HPO4, 3 mM KH2PO4,
44 mM NaCl, 10 gL21 glucose) and applied to a DE52 DEAE-
cellulose (Whatman) column that had been pre-equilibrated with
Author Summary
Animal African Trypanosomosis (AAT) is a set of diseases
whereby animals are infected with single-cell parasites that
replicate in their bloodstream. The disease in cattle results
in weight-loss and death, and AAT is a significant
veterinary problem for sub-Saharan Africa. One of the
principal trypanosome species responsible for AAT in
cattle is Trypanosoma congolense and, although there are
drug-treatments for these infections, current diagnostic
methods are impractical for field use. Our aim was to
discover protein molecules from the parasite to which
infected animals make antibodies, to then make these
proteins in bacteria and to subsequently demonstrate that
they can be used to detect antibodies in cattle serum, thus
diagnosing AAT. To discover the diagnostic proteins, we
dissolved parasites in a detergent solution and applied
them to beads coated with antibodies from infected cattle
and to beads coated with antibodies from un-infected
cattle. We then compared the proteins bound to each and
selected those proteins that were at least 100-fold
enriched by the infected cattle antibodies. We refined this
list, according to practical and performance considerations,
and settled on one protein, called Tc38630. Testing
Tc38630 with cattle sera showed that it can detect about
nine out of ten AAT infections.
Diagnostic Antigens for Trypanosoma congolense
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SB+glucose. The trypanosomes were washed through the column
with SB+glucose, counted, centrifuged (900 g, 15 min, 4uC),
resuspended in 1 ml PBS and then adjusted to 3.76107 parasites
mL21 in 20 ml ice-cold lysis buffer (50 mM Na2PO4, pH 7.2, 2%
n-octyl b-D-glucopyranoside (nOG) detergent, 1 mM PMSF,
1 mM TLCK, 1 mg mL21 aprotinin, 1 mg mL21 leupeptin and
16 Roche protease cocktail minus EDTA). The lysate was
incubated for 30 min on ice and then centrifuged at 100,000 g for
1 h at 4uC.
Immunoprecipitation
Identical aliquots of T. congolense lysate (76108 cell equivalents)
were incubated in parallel with 0.5 ml packed volume of each of
the CNBr Sepharose-IgG (post-infection and pre-infection) gels,
rotating for 3 h at 4uC. The gels were then packed into disposable
10 ml columns and washed with 10 ml of 10 mM Na2PO4,
pH 7.2, 200 mM NaCl, 1% nOG, followed by 10 ml of 5 mM
Na2PO4 pH 7.2, 1% nOG. The trypanosome proteins were eluted
with 500 ml of 50 mM sodium citrate, pH 2.8, 1% nOG into tubes
containing 100 ml of 1 M Tris pH 8.5 for neutralization. The
eluates were further concentrated to 270 ml using a centrifugal
concentrator (Millipore, 0.5 ml capacity with 10 kDa MW cut off
membrane). The concentrates containing the trypanosome pro-
teins were then transferred to low binding Eppendorf tubes and
the proteins precipitated by adding 1 ml ice-cold ethanol and
incubation for 24 h at 220uC.
Proteomic protein identification
Following ethanol precipitation, the proteins eluted from the
post-infection IgG and pre-infection IgG columns were dissolved
in SDS sample buffer, reduced with DTT and run on a precast 4–
12% Bis-Tris gradient SDS-PAGE (Invitrogen) using the MES
running system. The gel was stained with colloidal Coomassie blue
and equivalent regions of the infection and control lanes were cut
out, reduced and alkylated with iodoacetamide and digested in-gel
with trypsin. The tryptic peptides were analysed by LC-MS/MS
on a Thermo Orbitrap XL system and MaxQuant software was
used to match peptides to the predicted trypanosome protein
databases (combined GeneDB and UniProt predicted protein
sequences).
Data analysis
The program MaxQuant was used to obtain relative intensity
data of the peptides recovered from the post-infection and pre-
infection (control) IgG columns. This produced a list of 98 proteins
found uniquely in the eluate of the infection IgG column ranked
by relative intensity (Table S1 in Text S1). A second list of proteins
with a .100-fold higher abundance in the post-infection eluate
than the pre-infection eluate (15 proteins) was also selected (Table
S1 in Text S1). Proteins with peptide coverage under 10% were
discarded.
TriTrypDB [14] was used to obtain the predicted protein
sequences and names of the selected proteins. Most were
annotated as ‘‘hypothetical proteins’’, in these cases if a
trypanosomatid homologue was annotated this name was used.
The list was visually inspected and ubiquitin, ribosomes and large
structural proteins such as those from the paraflagellar rod and
clathrin were removed.
The sequences were further examined against different NCBI
databases in order to prioritise targets for recombinant production.
The closest homologues (from any organism, trypanosomatid,
bovine and humans) were noted. Any close homologues that had
produced crystal structures and/or had domains identified by
Conserved Domain Database (CDD) [15] were also noted.
A shortlist of proteins was chosen for expression and purification
trials based on uniqueness to T. congolense (,33% identity to
human or bovine homologs) and perceived ease of expression in E.
coli [16]. Several of these proteins appear to be unique to T.
congolense, with no close homologues in T. brucei or other
trypanosomatids. Proteins with homologues in the PDB were
considered favourable for expression, as were proteins less than
50 kDa. These were checked using XtalPred [16] for major areas
of disorder, coiled coils, signal peptides and transmembrane
domains. This produced a list of 15 potential diagnostic protein
antigens for expression trials (Table S1 in Text S1).
A pilot IP was initially preformed (data not shown) which
produced a shortlist of 14 proteins uniquely recognised by the
post-infection IgGs. Twelve of these were selectively recognised by
the post-infected IgG eluant in the second IP described here.
However, from this list only two proteins, TcIL3000.0.38630 and
TcIL3000.2.1660 passed the infection:control ratio cutoff (.100-
fold higher abundance in the post-infection eluate than the pre-
infection eluate). Three additional proteins were produced solubly
and are described here. However, their infection:control ratios
were low with only 2–4 times enrichment in the infected IgG
eluant.
In total, seven proteins could be produced as soluble proteins in
sufficient quantities for assessment.
Cloning
Most of the genes listed in Table 1 were amplified by PCR,
using the primers described, from T. congolense genomic DNA
(kindly provided by Mark Carrington, University of Cambridge)
and ligated into pCR2.1-TOPO using the TOPO TA Cloning Kit
(Invitrogen). The exception was the gene encoding Tc38630,
which was made as a synthetic gene by GenScript in a pUC vector
with restriction sites (Nde1 and Xho1) in place for downstream
cloning. The coding sequence was optimized to avoid rare codon
combinations in E. coli and disfavoured mRNA structures and cis
elements for protein expression. All of the coding sequences were
inserted into a pET15b-derived plasmid (Novagen) modified to
include a tobacco etch virus (TEV) protease cleavage site between
the His6 tag and the coding sequence. Genes for Tc38630,
Tc29290 and Tc51750 were also inserted into a modified
pET15b-derived plasmid encoding for a TEV cleavable histidine
tagged maltose binding protein (kind gift of Dr. Thomas
Eadsforth). Recombinant protein expression was achieved with
E. coli BL21-CodonPlus (DE3) RIPL cells (Stratagene) in
autoinduction medium containing 50 mg mL21 ampicillin and
12 mg mL21 chloramphenicol, with the exception of Tc38630
constructs which were expressed in BL21 Gold (DE3) cells in the
presence of 50 mg mL21 ampicillin.
Expression and purification of recombinant protein
targets
Cells were grown for 24 h at room temperature, harvested by
centrifugation (3,5006 g, 30 min, 4uC) and lysed with a French
press in buffer A (50 mM Tris-HCl, pH 7.5, 250 mM NaCl). Cell
debris was removed by centrifugation at 25,0006 g (30 min, 4uC).
The proteins were captured using nickel affinity chromatography
on a 5 ml HisTrap column (GE Healthcare) and eluted using an
imidazole gradient. This was followed by dialysis into buffer A and
proteolytic cleavage of the histidine tag with 1 mg TEV protease
per 20 mg protein (4uC, 16 h). The TEV protease carries a
histidine tag and so the application of the sample to another
HisTrap column removed the protease, any uncleaved protein and
the histidine tag itself from the cleaved product, which passed
through the column. Size exclusion chromatography on a
Diagnostic Antigens for Trypanosoma congolense
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Superdex 200 26/60 column provided the final stage in
purification. With the exception of Tc3710, a final polishing step
was performed on a Superose 12 10/30 column. All proteins were
.95% pure, as judged by sodium dodecyl sulphate polyacryl-
amide gel electrophoresis (SDS PAGE) and Coomassie blue
staining (Figure S1 in Text S1). The amino acid sequences of the
successfully expressed protein domains are shown in (Table S2 in
Text S1).
Enzyme Linked Immunosorbent Assay (ELISA)
White polystyrene Costar untreated plates were coated with
50 ml per well of target protein at a concentration of 2 mg mL21 in
plating buffer (0.05 M NaHCO3, pH 9.6) for 3 h at room
temperature. The plates were then treated overnight at 4uC with
PBS containing 5% bovine serum albumin (BSA) and 0.1%
Tween-20 to block non-specific adsorption sites. Calf sera were
serially diluted from 1:500 to 1:16000 and transferred in triplicate
by a liquid handling device (Bio-Tek, Precision) to the ELISA
plates and incubated for 1 h at room temperature after which they
were aspirated and the wells washed with PBS containing 0.1%
BSA using the liquid handling device. This wash cycle was
repeated 5 times. Biotinylated anti-bovine-IgG (Jackson labs) was
added at a dilution of 1:4000 and incubated for 1 h. Excess anti-
bovine-IgG antibody was washed away (as described before) and
50 ml per well of ExtrAvidin-Horse Radish Peroxidase (HRP) at a
dilution of 1:4000 was added to the plates and incubated for 1 h.
The solution was aspirated and the wash steps were repeated.
Finally, chemiluminescent Femto substrate (Pierce) diluted 1:5 (i.e.,
0.5 ml solution A, 0.5 ml solution B with 4 ml PBS) was applied to
the wells at 50 ml per well and plates were read using an Envision
plate reader after 2.5 min incubation at 22uC.
Data analysis and statistics
Bar graphs were generated using Microsoft Excel. Box plots and
Receiver Operator Characteristic (ROC) curves were generated
using IBM SPSS software. Wilcoxon’s signed rank test was used to
establish the statistical significance of the antibody response on 28
days post infection versus that on each of the post treatment
values.
Results
Proteomics approach to diagnostic antigen selection
A proteomics approach was used to identify proteins selectively
recognised by the IgG fraction of pooled sera from T. congolense
infected calves, with the IgG fraction of pooled sera obtained from
the same calves prior to infection used as the control. This was
achieved by following previously established methods [7]. Briefly,
IgG from pooled pre- and 28 day post-infected cattle sera were
immobilised onto Sepharose beads and incubated with T. congolense
lysate. The bound and subsequently eluted proteins were
separated by SDS-PAGE. Gel slices were subjected to S-alkylation
and tryptic digestion and the tryptic peptides were analysed by
LC-MS/MS. These peptides were matched to proteins in the T.
congolense database and relative intensities assigned using Max-
Quant software. This process identified 113 proteins that were
either unique or .100-fold more abundant in the eluate from the
infection IgGs compared to the eluate from the pre-infection IgGs
(Table S1 in Text S1). A large percentage of the proteins thus
identified were ‘hypothetical’. The proteins were therefore
tentatively assigned to protein family groups based on homology
to other annotated trypanosomatid sequences and/or protein fold
identification from the CCD [16]. The identified proteins (Table
S1 in Text S1) are mostly surface glycoproteins such as variant
surface glycoprotein B (VSG_B), expression site associated genes
(ESAGs), invariant surface glycoproteins (ISGs), trans-sialidases,
unknown proteins that have signal peptides and/or transmem-
brane domains and proteins involved in trafficking such as soluble
NSF attachment protein receptors (SNAREs). These surface and
secretory pathway glycoproteins are similar to the proteins
identified in a comparable study using human Trypanosoma brucei
gambiense infection and control IgGs [7]. Fifteen of the identified T.
congolense proteins were selected for expression trials based on
assessment for predicted ease of expression in E. coli. This
assessment utilized prior knowledge of the features of ‘‘difficult to
express’’ protein families, such as the presence of multiple
transmembrane domains, regions of protein disorder and regions
of low complexity [16]. The selected proteins were put into
expression trials as full-length constructs or as truncated constructs
when single transmembrane domains and/or signal peptides
Table 1. The proteins expressed in this study, their TriTrypDB gene identifiers, the residue ranges expressed and the primers used
to PCR amplify them from T. congolense genomic DNA.
Protein ID
TriTrypDB
gene ID Residue range Forward primer (59 to 39)
Reverse primer
(59 to 39)
Tc38630 TcIL3000.0.38630 30–355 N/A N/A
Tc2530 TcIL3000.9.2530 1–346 (full length) C A T A T G A G G C G A G G G C G T G T G G A T C C T T A C A T T G A C T C A C
G C A A C T C A G C
Tc5750 TcIL3000.10.5750 1–311 (full length) C A T A T G T C A A C A A C A G A T A A A T T T C
C G
C T C G A G T C A A G C C G C A G A T
G G A C C
Tc3710 TcIL3000.7.371 1–142 (full length) C A T A T G T C C A G T T G T A T A T T C T G C A
G G
C T C G A G T T A C A G C A C C T T C T
C C A A T G C
Tc29290 TcIL3000.0.29290 26–362 C A T A T G G C T G G C A A T T C T A A T G G T G
T C
C T C G A G T T A G C T C T C C T T T G
A A T G G G C A
Tc51750 TcIL3000.0.51750 36–364 C A T A T G C T A G A C A G G T T C G G T G C C T C G A G T T A C C C C T T T G G A G
T C T C A G T A C G
Tc03060 TcIL3000.0.03060 28–374 C T C G A G A C C G A A G A A G C G A A A A C A
T T T
G G A T C C T T A T T T T G C C A T C A
C A A A G A G C C
Bold letters are encode the restriction sites.
doi:10.1371/journal.pntd.0002936.t001
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needed to be removed to assist soluble protein expression
(Table 1).
Recombinant protein production and preliminary
assessment by ELISA
Constructs encoding all or part of the fifteen selected proteins
were cloned into a modified pET15bTEV vector which allowed
for the production of histidine tagged proteins which could be
purified by immobilised metal affinity chromatography followed
by tag removal and further purification by size exclusion
chromatography. Seven proteins were successfully purified in
monomeric form to .95% purity (Figure S1 in Text S1). The
remainder were expressed in inclusion bodies and were not
pursued further.
The successfully expressed and purified monomeric recombi-
nant proteins (Table S1 in Text S1) were tested in ELISA assays
for their reactivity to cattle sera. In the initial experiments, we used
pooled pre-infection (day 27) and post-infection (day +28) sera
(Figure 1). All antigens tested showed significant significant
differences in immunoreactivity between pre- and posrt-infection
sera (i.e, paired T-test p,0.05).
From this initial assessment, three proteins, all members of the
ISG family (Tc38630, Tc29290 and Tc51750), were selected for
further investigation as they had post- to pre- infection signal ratios
.3. The four other proteins, a member of the PNP_UDP1
superfamily (Tc2530), a tyrosine specific protein phosphatase
(Tc5750), an adenosine 59-monophosphoramidase (Tc3710) and a
transferrin receptor-like/PAG-like protein (Tc03060) had relative-
ly poor immunoselectivity ratios and were not progressed further.
Improved recombinant protein production and
assessment of Tc38630, Tc29290 and Tc51750 by ELISA
with individual sera
We found that the addition of an N-terminal maltose binding
protein (MBP) affinity tag to the T. congolense protein constructs
generally increased the expression and overall yield of the
recombinant proteins by about 20-fold. However, as MBP is an
E. coli-derived protein it was thought prudent to remove it by
proteolytic cleavage before assessing the immunodiagnostic
potential of the antigen. This reduced the final yield improvement
for the monomeric recombinant protein to about 3-fold. MBP-
fusion expressed (with tag subsequently removed) typical yields for
Tc38630, Tc29290 and Tc51750 were 2 mg/L, 0.3 mg/L and
4 mg/L respectively. Viable quantities of Tc29290 can only be
obtained using the fusion protein.
Purified, MBP-tag cleaved and monomeric (by gel filtration)
forms of Tc38630, Tc29290 and Tc51750 were used to create
ELISA plates for testing with 40 individual pre- (day 27) and post-
infection (day +28) calf sera.
To judge the sensitivity and specificity of each of the three
ELISA assays, receiver operating characteristic (ROC) curve
analysis was performed. The recombinant Tc38630 protein, with
a ROC curve area of 0.954 was clearly superior to Tc29290 and
Tc51750 for diagnostic potential (Figure S2 in Text S1).
Figure 1. Assessment of the diagnostic potential of recombinant proteins by ELISA. Recombinant proteins were tested by ELISA using
pooled sera from the same 40 calves before (day 27; blue bars) and after (day +28; red bars) experimental infection with T. congolense. The mean
relative light units (RLU) 6 SEM from the triplicate measurements are shown.
doi:10.1371/journal.pntd.0002936.g001
Diagnostic Antigens for Trypanosoma congolense
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Evaluation of the diagnostic potential of Tc38630
Tc38630 was taken forward to be tested with 77 randomised
and blinded pre- and post-infection calf sera. Based on the
previous data, we selected an initial cut-off of 650000 relative light
units (RLU) to predict infected (.650000 RLU) and uninfected (,
650000 RLU) calves. Following decoding of the data and ROC
curve analysis (Figure 2), we found that Tc38630 ELISA gave a
sensitivity of 87.2% and specificity of 97.4%. Exploring alternative
cutoff values (Table 2) we can see that the optimal sensitivity of the
assay is achieved with a cutoff of 418686 RLU which gave a
sensitivity and specificity of 94.9% and 89.5%, respectively.
Scatter and box plots indicating the ranges of ELISA readings
obtained with pre- and post-infection sera are shown in (Figure 2B
and 2C).
It is worth noting that it has been previously reported that this
antigen does not cross react with the common non-pathogenic
cattle trypanosome T. theileri [11].
Antibody response to Tc38630 correlates with post-
treatment infection status
In order to determine if immunoreactivity to Tc38630 might
distinguish successful from failed drug-treatment, we first tested sera
taken at several time points from 40 calves subjected to experimental
infection and drug treatment 35 days later. When the cattle infection
status was taken into account (assessed by the presence or absence of
parasitemia at day 98) two distinct antibody responses were noted.
Thus, relative to immunoreactivity at day 28, persistent and higher
immunoreactivity to Tc38630 correlated with presence of parasit-
aemia at day 98, i.e., failed drug treatment (Figure 3B), while lower
immunoreactivity to Tc38630 correlated with aparasitaemia at day
98, i.e., successful drug treatment (Figure 3A).
When analysed at the level of individual animal responses, we
noticed that the sera from ‘drug-cured’ animals, i.e., those
aparasitaemic at the end of the experiment, typically showed a
two-wave antibody response to Tc38630 (Figure 4, A and B),
whereas animals that remained infected at the end of the study
show a constant rise in immunoresponsivenss to Tc38630
(Figure 4, C and D).
Taken together, these data suggest that Tc38630 may have the
potential to distinguish successful and failed drug treatments by
comparing ELISA titres shortly before treatment with those .50
days later.
Discussion
In this study, for practical reasons, we have used T. congolense
cells propagated in mice to generate bloodstream form parasite
lysates for affinity chromatography on immobilized bovine IgG
matrices. Since it is conceivable that host animal environment may
influence parasite gene expression, we must acknowledge that
there may consequently be limitations in the list of specifically-
recognized antigens (Table S1 in Text S1). Nevertheless, three
proteins belonging to the invariant surface glycoprotein (ISG)
family (Tc38630, Tc45510 and Tc29290) were successfully
identified as potential diagnostic antigens by proteomic selection
followed by assessment of likely ease of expression in E. coli
followed by protein expression trials. The best performing of these,
Tc38630, was also recently reported as a potential diagnostic
antigen for T. congolense infections using experimental mouse sera
[11]. Although annotated as hypothetical in the genome database,
Tc38630 has been previously identified by quantitative proteomics
as being most abundant on the metacyclic and bloodstream
trypomastigote forms of T. congolense [17].
Figure 2. Evaluation of the diagnostic potential of Tc38630 in ELISA assay with pre- and post-infection calf sera. (A) ELISA plates
coated with recombinant Tc38630 were tested with 77 blinded and randomised pre (n = 38) and post-infection (n = 39) calf sera. (B) After decoding
the results and using a pre-defined cut-off, the data were plotted as ROC curves of specificity against sensitivity (1-specificity). The boxes represent
the 25th to 75th percentiles, the horizontal line within the box represents the median value and the whiskers indicate the 10th and 90th percentiles.
doi:10.1371/journal.pntd.0002936.g002
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The ISGs have, thus far, only been characterised in T. brucei,
where ISG65 and ISG75 have been shown to be moderately
abundant (50000 to 70000 copies per cell) type-1 integral
membrane cell surface glycoproteins [18]. While the physiological
function of the ISGs is unclear, they are known to be endocytosed
and recycled [19] and ISG75 has been implicated as the principal
receptor for the uptake of the drug suramin [20]. The surface
location, reasonable abundance and lack of similarity with any
mammalian proteins most likely all contribute to the immunoge-
nicity of ISGs in animal infections. Indeed, ISGs have been
proposed and/or used as diagnostic antigens for human or animal
infections with T. brucei gambiense [7,21], T. evansi [22] and T.
Table 2. Sensitivity and specificity scores at different RLU cut-offs.
Cutoff. Sensitivity % 95% CI Specificity % 95% CI
298493 97.44 86.52% to 99.94% 63.16 45.99% to 78.19%
309600 94.87 82.68% to 99.37% 63.16 45.99% to 78.19%
319127 94.87 82.68% to 99.37% 65.79 48.65% to 80.37%
324493 94.87 82.68% to 99.37% 68.42 51.35% to 82.50%
327533 94.87 82.68% to 99.37% 71.05 54.10% to 84.58%
343107 94.87 82.68% to 99.37% 73.68 56.90% to 86.60%
362373 94.87 82.68% to 99.37% 76.32 59.76% to 88.56%
370027 94.87 82.68% to 99.37% 78.95 62.68% to 90.45%
379000 94.87 82.68% to 99.37% 81.58 65.67% to 92.26%
386747 94.87 82.68% to 99.37% 84.21 68.75% to 93.98%
395113 94.87 82.68% to 99.37% 86.84 71.91% to 95.59%
"418647 94.87 82.68% to 99.37% 89.47 75.20% to 97.06%
441513 92.31 79.13% to 98.38% 89.47 75.20% to 97.06%
472200 89.74 75.78% to 97.13% 89.47 75.20% to 97.06%
525140 87.18 72.57% to 95.70% 89.47 75.20% to 97.06%
556413 87.18 72.57% to 95.70% 92.11 78.62% to 98.34%
588580 87.18 72.57% to 95.70% 94.74 82.25% to 99.36%
#649520 87.18 72.57% to 95.70% 97.37 86.19% to 99.93%
696160 84.62 69.47% to 94.14% 97.37 86.19% to 99.93%
736407 82.05 66.47% to 92.46% 97.37 86.19% to 99.93%
761707 79.49 63.54% to 90.70% 97.37 86.19% to 99.93%
762747 76.92 60.67% to 88.87% 97.37 86.19% to 99.93%
794293 76.92 60.67% to 88.87% 100
#pre-unblinding cut-off; ", optimal cut-off deduced after un-blinding the data.
doi:10.1371/journal.pntd.0002936.t002
Figure 3. Differential immunoreactivity of sera from animals with aparasitaemia and parasitaemia post-treatment to recombinant
Tc38630. ELISA data from cattle sera at different days post-infection are represented as box plots. The boxes represent the 25th to 75th percentiles,
the horizontal line within the box represents the median value and the whiskers indicate the 10th and 90th percentiles. The cattle were negative (A) or
positive (B) for parasitaemia at the end of treatment. The day of treatment is indicated by a black arrow.
doi:10.1371/journal.pntd.0002936.g003
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congolense [11]. Nevertheless, choosing which of the many (49 in the
case of T. congolense) ISG protein sequences in each trypanosome
species [23] to select for protein expression and ELISA trials is a
daunting task without the prioritisation provided by the proteomic
approach taken in [7] for T. brucei and in this paper for T.
congolense. Other selection criteria can lead to disappointing results;
for example, the T. congolense ISG with the greatest similarity to
that selected for the diagnosis of human T. brucei gambiense
infections proved to be poor for the diagnosis of T. congolense
infections in cattle (unpublished data). Further, although there is a
lack of ISG sequence similarity between trypanosome species
(typically ,10% sequence identity and ,20% sequence similarity)
[23] it would be premature to assume that immunoreactivity to
Tc38630 is specific for T. congolense bovine infections over T. brucei
and T. vivax infections, and this issue awaits analysis.
In summary, we have identified a member of the invariant
surface glycoprotein family (Tc38630) as a diagnostic antigen for
the detection of T. congolense infection in cattle. It is known that
serum antibody persistence in Trypanosome infected cattle after
curative treatment, or self-cure, is on average 3–4 months [24] and
can be up to 13 months [25]. At the point of care, an ideal
diagnostic antigen would be able to indicate active cattle infections
with high sensitivity and specificity and be able to accurately track
drug efficacy. The latter requires that immunoreactivity to the
antigen is maintained in continuing infections and significantly
reduces following cure. The data provided here suggests that this
may well be the case for the recombinant Tc38630 protein
construct. Therefore, further development of this antigen into
lateral flow devices may be warranted. Nevertheless, it must be
acknowledged that antigen, as opposed to antibody, detection tests
are undoubtedly better for monitoring pathogen burden and drug
efficacy. Unfortunately, antigen detection systems for AAT are
currently lacking.
Supporting Information
Text S1 Figure S1. SDS-PAGE with Coomassie blue
staining of purified recombinant proteins. The names of
the expressed proteins appear above each respective gel lane. The
bands indicated by arrow heads are: A, Tc38630; B, degradation
product of Tc38630; C, E. coli Ef-Tu (co-purifying contaminant);
D, Tc29290. These identities were confirmed by tryptic digestion
and mass spectrometry. Figure S2. Assessment of Tc38630,
Tc29290 and Tc51750 ELISA assays with pre- and post-
infection calf sera. (A) ELISA plates coated with the three
recombinant proteins were tested with pre-infection (day 27;
n = 40) and post-infection (day +28; n= 40) calf sera. The data
were plotted on RoC curves of specificity against selectivity (1-
specificity). The output statistics show a sensitivity and specificity
of 90% and 94.2% for Tc38630, 80% and 67.3% for Tc29290 and
82.5% and 67.3% for Tc51750, respectively. Table S1.
Antigens selectively recognised by T. congolense infec-
tion IgG. The antigens are ordered by infection : control LC-
MS/MS intensity and . coloured coded according to their by LC-
MS/MS intensities: black bold .1000, black .60, grey ,60.
Only antigens uniquely bound by infection IgG to or with high
intensity (.1000) and an infection : control ratio .100 were
assigned identities. Those that failed to yield soluble protein in
expression and purification trials are marked with&. Those selected
but untested in expression trials are marked with white rectangle
Figure 4. Representative examples of the immunoreactivity of sera to Tc38630 over time. The mean relative light units (RLU)6 SEM from
triplicate measurements of immunoreactivity over a time-course are shown. (A) and (B): responses of cattle aparasitemic at the end of the study
treated 35 and 10 days post-infection, respectively. (C) and (D): response of cattle with detectable parasitemia at the end of the study treated 35 and
10 days post-infection, respectively. The day of treatment is indicated by a black arrow.
doi:10.1371/journal.pntd.0002936.g004
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(vectors available on request) and those purified successfully are
marked white rectangle.
Table S2. Amino acid sequences of the seven antigen
domains successfully expressed in E. coli. Differences in
sequence to those in the TriTrypDB are highlighted in red, these are
probably due to strain variation.
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Acknowledgments
We thank Kenny Beattie, Dougie Lamont, Sam Kosto and Wenzhang
Chen for proteomic support, Grant Napier at GALVmed for project
coordination and Dr Claudia Cordel, Heidi Erasmus and Michel
Labuschagne at ClinVet for clinical studies and sera supply. T. congolense
isolates 02J and 31J were kindly provided by Luis Neves (University of
Eduardo Mondlane, Mozambique) and isolates KONT2/133 and
KONT2/151 by Vincent Delespaux (Institute for Tropical Medicine,
Antwerp).
Author Contributions
Conceived and designed the experiments: JRF LSu MAJF. Performed the
experiments: JRF TWMC LSa. Analyzed the data: JRF LSa LSu MAJF.
Contributed reagents/materials/analysis tools: GBN. Wrote the paper:
JRF MAJF.
References
1. Schofield CJ, Kabayo JP (2008) Trypanosomiasis vector control in Africa and
Latin America. Parasit Vectors 1: 24. doi:10.1186/1756-3305-1-24.
2. Shaw A (2004) The Trypanosomiases - Ian Maudlin, Peter H. Holmes, Michael
A. Miles - Google Books. The trypanosomiases.
3. Coustou V, Plazolles N, Guegan F, Baltz T (2012) Sialidases play a key role in
infection and anaemia in Trypanosoma congolense animal trypanosomiasis. Cell
Microbiol 14: 431–445. doi:10.1111/j.1462-5822.2011.01730.x.
4. Delespaux V, Geysen D, Van den Bossche P, Geerts S (2008) Molecular tools for
the rapid detection of drug resistance in animal trypanosomes. Trends Parasitol
24: 236–242. doi:10.1016/j.pt.2008.02.006.
5. Uilenberg G (1998) A field guide for the diagnosis, treatment and prevention of
African animal trypanosomosis. The Food and Agriculture Organization of the
United Nations.
6. Desquesnes MM, Da´vila AMRA (2002) Applications of PCR-based tools for
detection and identification of animal trypanosomes: a review and perspectives.
Vet Parasitol 109: 213–231.
7. Sullivan L, Wall SJ, Carrington M, Ferguson MAJ (2013) Proteomic selection of
immunodiagnostic antigens for human african trypanosomiasis and generation
of a prototype lateral flow immunodiagnostic device. PLoS Negl Trop Dis 7:
e2087. doi:10.1371/journal.pntd.0002087.
8. Muller N, Hemphill A, Imboden M, Duvallet G, Dwinger RH, Seebeck T (1992)
Identification and characterization of two repetitive non-variable antigens from
African trypanosomes which are recognized early during infection. Parasitology
104: 111–120.
9. Pillay D, Izotte J, Fikru R, Buscher P, Mucache H, Neves L, Boulange A, Seck
MT, Bouyer J, Napier GB, Chevtzoff C, Coustou V, Baltz T (2013)
Trypanosoma vivax GM6 antigen: a candidate antigen for diagnosis of African
animal trypanosomosis in cattle. PLoS One 8: e78565.
10. Bossard G, Boulange A, Holzmuller P, Thevenon S, Patrel D, Authie E (2010)
Serodiagnosis of bovine trypanosomosis based on HSP70/BiP inhibition ELISA.
Vet Parasitol 173: 39–47.
11. Mochabo KM, Zhou M, Suganuma K, Kawazu S-I, Suzuki Y, et al. (2013)
Expression, immunolocalization and serodiagnostic value of Tc38630 protein
from Trypanosoma congolense. Parasitol Res 112: 3357–3363. doi:10.1007/
s00436-013-3515-z.
12. Geysen D, Delespaux V, Geerts S (2003) PCR-RFLP using Ssu-rDNA
amplification as an easy method for species-specific diagnosis of Trypanosoma
species in cattle. Vet Parasitol 110: 171–180.
13. Murray M, Trial JCM, Truner A, Wissocq Y (1983) Procedures for
determination of PCV (haematocrit) and Presence of Trypanosomes (phase
contrast buffy coat) in Cattle. Livestock productivity and trypanotolerance:
Network Training Manual. International Livestock Centre for Africa, Addis
Ababa, Ethiopia.
14. Aslett M, Aurrecoechea C, Berriman M, Brestelli J, Brunk BP, et al. (2010)
TriTrypDB: a functional genomic resource for the Trypanosomatidae. Nucleic
Acids Res 38: D457–D462. doi:10.1093/nar/gkp851.
15. Marchler-Bauer A, Zheng C, Chitsaz F, Derbyshire MK, Geer LY, et al. (2013)
CDD: conserved domains and protein three-dimensional structure. Nucleic
Acids Res 41: D348–D352. doi:10.1093/nar/gks1243.
16. Slabinski L, Jaroszewski L, Rychlewski L, Wilson IA, Lesley SA, et al. (2007)
XtalPred: a web server for prediction of protein crystallizability. Bioinformatics
23: 3403–3405. doi:10.1093/bioinformatics/btm477.
17. Eyford BA, Sakurai T, Smith D, Loveless B, Hertz-Fowler C, Donelson JE,
Inoue N, Pearson TW (2011) Differential protein expression throughout the life
cycle of Trypanosoma congolense, a major parasite of cattle in Africa. Mol
Biochem Parasitol 177: 116–125.
18. Ziegelbauer K, Multhaup G, Overath P (1992) Molecular characterization of
two invariant surface glycoproteins specific for the bloodstream stage of
Trypanosoma brucei. J Biol Chem 267: 10797–10803.
19. Koumandou VL, Boehm C, Horder KA, Field MC (2012) Evidence for
recycling of invariant surface trans-membrane domain proteins in African
trypanosomes. Eukaryotic Cell 12: 330–342. doi:10.1128/EC.00273-12.
20. Alsford S, Eckert S, Baker N, Glover L, Sanchez-Flores A, et al. (2012) High-
throughput decoding of antitrypanosomal drug efficacy and resistance. Nature
482: 232–236. doi:10.1038/nature10771.
21. Giroud C, Ottones F, Coustou V, Dacheux D, Biteau N, et al. (2009) Murine
Models for Trypanosoma brucei gambiense disease progression–from silent to
chronic infections and early brain tropism. PLoS Negl Trop Dis 3: e509.
doi:10.1371/journal.pntd.0000509.
22. Tran T, Claes F, Verloo D, De Greve H, Buscher P (2009) Towards a New
Reference Test for Surra in Camels. Clin Vaccine Immunol 16: 999–1002.
doi:10.1128/CVI.00096-09.
23. Jackson AP, Allison HC, Barry JD, Field MC, Hertz-Fowler C, et al. (2013) A
Cell-surface Phylome for African Trypanosomes. PLoS Negl Trop Dis 7: e2121.
doi:10.1371/journal.pntd.0002121.
24. Desquesnes MM (2004) Livestock Trypanosomoses and their Vectors in Latin
America. OIE and CIRAD (Centre de coope´ration internationale en recherche
agronomique pour le de´veloppement). World Organisation for Animal Health
(OIE), Paris, France, 192 p. ISBN 92-9044-634-X.
25. Van den Bossche P, Chigoma D, Shumba W (2000) The decline of anti-
trypanosomal antibody levels in cattle after treatment with trypanocidal drugs
and in the absence of tsetse challenge. Acta Trop 77: 263–270.
Diagnostic Antigens for Trypanosoma congolense
PLOS Neglected Tropical Diseases | www.plosntds.org 9 June 2014 | Volume 8 | Issue 6 | e2936
